---
title: "002755.SZ (002755.SZ) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/002755.SZ/news.md"
symbol: "002755.SZ"
name: "002755.SZ"
parent: "https://longbridge.com/en/quote/002755.SZ.md"
datetime: "2026-05-20T10:12:35.729Z"
locales:
  - [en](https://longbridge.com/en/quote/002755.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002755.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002755.SZ/news.md)
---

# 002755.SZ (002755.SZ) — Related News

### [The first quarter tops an entire year! Pharmaceutical transaction volume surges, innovative drug concept stocks are active, ASK PHARM hits the daily limit](https://longbridge.com/en/news/287000114.md)
*2026-05-20T03:29:09.000Z*
> On May 20th, A-share innovative drug concept stocks were active, and ASK PHARM hit the daily limit. The newly revised "R

### [The innovative drug concept performs actively, ASK PHARM hits the limit up](https://longbridge.com/en/news/286987655.md)
*2026-05-20T01:37:49.000Z*
> The innovative drug concept performed actively, with ASK PHARM hitting the limit up, and JinYao Pharmaceutical, QianYan 

### [Yangqin's revenue / February year-on-year increase of 250 million yuan sets a new high for the same period, Maiweideng's milestone of a thousand stores will be achieved](https://longbridge.com/en/news/278343084.md)
*2026-03-09T07:01:16.000Z*
> Yang Qin (2755) announced a revenue of NT$ 250 million for February, a year-on-year increase of 22.12%, setting a new re

### [ASK PHARM: Innovative drug Maltol Iron Capsules has received acceptance for drug registration and marketing license application](https://longbridge.com/en/news/277448912.md)
*2026-03-02T10:48:02.000Z*
> ASK PHARM's wholly-owned subsidiary Jiangsu ASK PHARM Co., Ltd. recently received the "Acceptance Notice" for the overse

### [Aosaikang: Subsidiary Aosaikang Pharmaceutical has reached a licensing introduction agreement with Arno Therapeutics](https://longbridge.com/en/news/270984636.md)
*2025-12-29T10:54:40.000Z*
> ASK PHARM announced that its subsidiary, ASK PHARM, has reached a licensing agreement with Arno Therapeutics to obtain e

### [Aosaikang: Injectable Delafloxacin Mesylate has obtained a drug registration certificate](https://longbridge.com/en/news/270484713.md)
*2025-12-22T11:34:03.000Z*
> Aosaikang announced that its wholly-owned subsidiary Jiangsu Aosaikang Pharmaceutical Co., Ltd. has obtained the drug re

### [Aosaikang: Innovative drug Liraglutide tablets included in the national medical insurance catalog](https://longbridge.com/en/news/268872712.md)
*2025-12-08T00:08:05.000Z*
> ASK PHARM announced that its innovative drug Liratinib Tablets (brand name: Aoyi Xin®) has been included in the National